The Journal of Allergy and Clinical Immunology: In Practice
Review and Feature ArticleThe Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia
Section snippets
Serum Tryptase Origin and Composition
Elevated tryptase is a hallmark of HαT and is not an uncommon finding in allergy/immunology patients, or indeed the general population. Tryptases are almost exclusively MC derived. Basophils, which are the only other cell type known to secrete α- and ß-tryptase in healthy individuals, produce <1% of the tryptase that MCs produce.1 Pre-tryptase, a 274-amino-acid peptide, is processed into the 257-amino-acid pro-tryptase; some amounts of these pro-tryptases are constitutively secreted by
Tryptase Genetics
The tryptase locus on chromosome 16p13.3 contains 4 tryptase genes: TPSB2 encoding at least 3 beta tryptase isoforms (ßI, ßII, and ßIII), TPSAB1 encoding α- or ß-tryptase isoforms (with ßIII not having been reported at this locus), TPSG1 encoding γ-tryptase, and TPSD1 encoding δ-tryptase.2,5,12,31 There is an additional tryptase gene, Serine Protease 22 (PRSS22), which lies just outside the tryptase locus on chromosome 16 and encodes ε-tryptase.2 Of the 5 known major tryptase isoforms, only α-
Other Genetic Variants Frequently Associated With HαT
Given that the tryptase locus is within a gene-dense region with significant genetic recombination, coinheritance of another functional genetic variant that may contribute to some of the symptoms associated with HαT is possible. A study by Lyons et al32 demonstrated the proof of this concept by identification of a frequently co-inherited haplotype of CACNA1H gene variants that lies adjacent to the tryptase locus on chromosome 16 and encodes a T-type voltage-gated calcium channel that is
HαT—A Common Cause Of Elevated sBT
The exact mechanism underlying how increased TPSAB1 copy number results in elevated sBT has not been proven, though sBT levels increase with additional TPSAB1 copy at a level greater than would be associated with gene replication alone. Primary basophils and cultured MCs from individuals with HαT express increased levels of tryptase transcripts, and these MCs have been shown to have increased spontaneous secretion of pro-tryptases in vitro.2,5 In contrast, total intracellular tryptase levels
Pathophysiologic Effects of Tryptases
Mature tryptases have been reported to play a role in DNA modification, tissue repair, vascular permeability, neutrophil and eosinophil chemotaxis, and thrombolysis.9,33, 34, 35, 36, 37 It has been shown that tryptase does play a role in histamine release, and that blocking mature tryptase decreases the detection of urinary histamine metabolites.38 ßI and ßII mature tetramers are peptidases and are important for neutrophil chemotaxis; less is known about ßIII, although based on sequence
Other Symptoms Reported Among Individuals With HαT
Whereas sBT levels are above 8 ng/mL in virtually all individuals who have been reported with HαT, associated symptoms are variably expressed and can manifest at any age, and the majority of individuals may not present with symptoms. In the only study to examine this, one-third of otherwise healthy adults with HαT had significant symptoms, one-third had mild-to-moderate symptoms, and one-third reported symptoms at the same frequency as healthy volunteers.5 Among symptomatic families recruited
HαT and Elevated sBT in the Context of Clonal and Nonclonal MC Disorders
It had been observed that numerous clinical similarities exist between individuals with HαT and individuals with clonal and non-clonal MC disorders, including MC activation syndrome (MCAS) and SM. Multiple studies have now demonstrated an increased prevalence of HαT in clonal and non-clonal MC disorders, and that this in turn is associated with increased anaphylaxis severity and frequency, as well as increased MC mediator symptoms among individuals with SM.9,10
The evolving diagnosis of MCAS
HαT is a Heritable Risk Factor for Severe Anaphylaxis and Modifies MC Disorders
Elevated tryptase is associated with an increased prevalence and severity of anaphylaxis, food-induced allergic reactions in children, and adverse reactions to drugs, contrast, insect stings, and venom immunotherapy.11,51, 52, 53, 54 In the initial studies describing patients with HαT, anaphylaxis was common; triggers included insect stings in 16% to 20% of individuals—a rate of 2 to 4 times that of the general population—as well as foods, drugs, radiocontrast, venom immunotherapy.2,5,55 In a
Treatment Approaches for Individuals With HαT
Treatments implemented for individuals with HαT are currently symptom-based. Because many of the symptoms are suggestive of MC mediator release, and there are data to support enhanced immediate hypersensitivity reactions in these individuals, H1 and H2 antagonists, leukotriene antagonists, MC stabilizers, and high-dose aspirin in specified cases are often used as first-line agents. Inhaled albuterol can be prescribed for those with bronchospasm. If there are severe symptoms consistent with
Conclusions
HαT is a common autosomal dominant genetic trait wherein excess α-tryptase encoding TPSAB1 copy number results in elevated sBT. HαT is associated with a variety of both allergic and non-allergic conditions, which is important for the allergist/immunologist to be aware of. Recently it has been shown that HαT is present in 4% to 6% of the general population and appears to account for the significant majority of individuals with elevated sBT.2,6, 7, 8, 9, 10, 11 Associated symptoms are variably
References (58)
- et al.
AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management
J Allergy Clin Immunol
(2019) Hereditary alpha tryptasemia: genotyping and associated clinical features
Immunol Allergy Clin North Am
(2018)- et al.
Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities
J Allergy Clin Immunol
(2014) - et al.
Familial hypertryptasemia with associated mast cell activation syndrome
J Allergy Clin Immunol
(2014) - et al.
Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression
J Allergy Clin Immunol Pract
(2020) - et al.
Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1
J Allergy Clin Immunol
(2021) - et al.
Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Blood
(2021) - et al.
Clinical characteristics and risk profile of patients with elevated baseline serum tryptase
Allergol Immunopathol
(2014) Tryptase genetics and anaphylaxis
J Allergy Clin Immunol
(2006)- et al.
Effect of sex and haplotype on plasma tryptase levels in healthy adults
J Allergy Clin Immunol
(2004)
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness
Blood
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy
J Allergy Clin Immunol
Persistent tryptase elevation in a patient with Gaucher disease
J Allergy Clin Immunol Pract
Targeting mast cells with biologics
Immunol Allergy Clin North Am
A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number
Genet Med
Tryptase, a mediator of human mast cells
J Allergy Clin Immunol
Tryptase-catalyzed core histone truncation: a novel epigenetic regulatory mechanism in mast cells
J Allergy Clin Immunol
Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft
J Biol Chem
Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders
Pulm Pharmacol Ther
The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region
J Mol Biol
The epidemiology of irritable bowel syndrome in North America: a systematic review
Am J Gastroenterol
Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
J Allergy Clin Immunol
Association of postural tachycardia syndrome and Ehlers-Danlos syndrome with mast cell activation disorders
Immunol Allergy Clin North Am
2016 updated WHO classification and novel emerging treatment concepts
Blood
Usefulness of testing for hereditary alpha tryptasemia in symptomatic patients with elevated tryptase
J Allergy Clin Immunol Pract
Human mast cell tryptase in biology and medicine
Mol Immunol
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
Nat Genet
Factors influencing serum total tryptase concentrations in a general adult population
Clin Chem Lab Med
Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease
J Nephrol
Cited by (0)
This research was supported in part by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
Conflicts of interest: K. T. Luskin and J. J. Lyons declare no relevant conflicts of interest. A. A. White has served on the advisory boards for Blueprint Pharmaceuticals, Genentech, GSK, and Regeneron; is on the speaker's bureau for GSK, Astra Zeneca, and Optinose; and is a grant recipient from AstraZeneca.